SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
NEW DEVELOPMENTS IN TRANSMITTED AND ACQUIRED DRUG RESISTANCE
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
MONITORING OF HIV DRUG RESISTANCE AMONG SEROCONVERTERS ON PREP IN KENYA (ABSTRACT
427)
Bhavna Chohan
University of Washington, Seattle, WA, USA
ULTRASENSITIVE HIV-1 DRUG-RESISTANCE ANALYSIS IN THE DISCOVER PREP TRIAL (ABSTRACT
428)
Stephanie Cox
Gilead Sciences, Inc, Foster City, CA, USA
IMPACT OF M184V ON THE VIROLOGICAL EFFICACY OF SWITCH TO 3TC/DTG IN REAL LIFE (ABSTRACT
429)
Maria Mercedes Santoro
University of Rome Tor Vergata, Rome, Rome, Italy
HIV WITH TRANSMITTED DRUG RESISTANCE IS DURABLY SUPPRESSED BY B/F/TAF AT WEEK 144 (ABSTRACT
430)
Rima K Acosta
Gilead Sciences, Inc, Foster City, CA, USA
DRUG RESISTANCE DURING LOW-LEVEL HIV VIREMIA SUPPORTS LOWERING THRESHOLD FOR SWITCH (ABSTRACT
431)
Jennifer A Brown
Swiss Tropical and Public Health Institute, Basel, Switzerland
EVALUATION OF COMBINATIONS OF CLINICAL INTEGRASE MUTATIONS ON INSTI RESISTANCE (ABSTRACT
432)
Peter K Cheung
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada
PUBLIC AVAILABILITY OF HIV POL SEQUENCES AND ART HISTORIES IN ACQUIRED HIVDR STUDIES (ABSTRACT
433)
Soo-Yon Rhee
Stanford University, Palo Alto, CA, USA
ANALYSIS OF INTRAHOST GAG-POL EVOLUTION WITH NOVEL SINGLE-MOLECULE SEQUENCING METHOD (ABSTRACT
434)
Christian M Gallardo
Seattle Children's Research Institute, Seattle, WA, USA
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
